Cargando…
Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4
INTRODUCTION: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that is characterized by joint inflammation, and progressive cartilage and bone erosion. Recent research has identified certain biologic agents that appear more able than conventional therapies to halt effectively the p...
Autores principales: | Kim, Seon Hee, Evans, Christopher H, Kim, Sunyoung, Oligino, Thomas, Ghivizzani, Steven C, Robbins, Paul D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC17812/ https://www.ncbi.nlm.nih.gov/pubmed/11056670 |
Ejemplares similares
-
Future of adenoviruses in the gene therapy of arthritis
por: Evans, Christopher H, et al.
Publicado: (2001) -
Protection against cartilage and bone destruction by systemic
interleukin-4 treatment in established murine type II collagen-induced
arthritis
por: Joosten, Leo AB, et al.
Publicado: (1999) -
Gene therapy for cartilage healing
por: Ghivizzani, SC, et al.
Publicado: (2001) -
T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis
por: Malmström, Vivianne, et al.
Publicado: (2000) -
Induction of synovial apoptosis by gene transfer and peptide mediated protein transduction
por: Oligino, TJ, et al.
Publicado: (2001)